Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Gordon Reid
Amedisys IncAMEDPAST TOP PICKFeb 02, 2011
(A Top Pick Feb 17/10. Down 40.3%.) Likes the home health care industry. Difficulty is the unknown regarding government reimbursement act, which is still up in the air. Very volatile.
Gordon ReidOwned
$35.15
Stock price when the opinion was issued
$100.99
As of Aug 14, 2025. Market Open.
medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
HOLD
Been a tough industry and tough company to own. Has been in the crosshairs of some of the regulators in Washington but the business is sound. It's home healthcare. People would rather be treated at home than in hospital and it's cheaper. Will probably earn over $4 a share this year, which is pretty attractive.
medical services
TOP PICK
Home health care company for acute patients. Contributor to health care reform. Least expensive option for health care. Stock suffered from the overhang of health care reform. Recently doubled his position as a result of management changes and skittish market.
Gordon ReidOwned
medical services
BUY
Healthcare company involved in home healthcare. Has done very well and will continue to do so. Was held back because of fears of the US government changes in healthcare. Extremely well managed and trading at only 8X earnings.
Gordon ReidOwned
medical services
